BENF
Beneficient3.7400
-0.2800-6.97%
Dec 16, 4:00:02 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
FY Q3 '26
Key Stats
Market Cap
51.89MP/E (TTM)
-Basic EPS (TTM)
-107.20Dividend Yield
0%Recent Filings
8-K
1-for-8 reverse split filed
Beneficient filed for a 1-for-8 reverse stock split on December 10, 2025, effective December 15, to regain Nasdaq compliance on minimum bid price. This slashes outstanding Class A shares from ~110.8M to ~13.8M and authorized shares from 5B to 625M. No fractional shares; extras issued instead. Trading resumes split-adjusted under BENF.
8-K
Chairman Hicks passes away
Beneficient announced the passing of Board Chairman Thomas O. Hicks on December 6, 2025, at age 79. The private equity pioneer, who joined the board in 2017 and became chairman in July 2025, brought decades of buy-and-build expertise. Board and management commit to his vision. Leadership continuity holds firm.
8-K
Reverse split approved
Beneficient stockholders overwhelmingly approved a reverse stock split on December 1, 2025, at a special meeting with 92.8% voting power present. The split ratio—any whole number from 1-for-5 to 1-for-100—falls to the Board's discretion, paired with a proportionate cut in authorized shares. Approval passed with 104M+ FOR votes. Board now holds implementation power.
10-Q
Q2 FY2026 results
Beneficient posted Q2 FY2026 revenue of -$2.8M, down from $8.6M y/y, as $3.2M investment loss replaced prior $8.5M gain from alternative assets held by Customer ExAlt Trusts; Ben Liquidity interest income fell 29% y/y to $8.5M (derived), offset by $5.5M credit provision. Operating loss widened to $17.9M from $13.7M y/y, driven by $62.8M arbitration award accrual after appeals court reversal—net loss attributable to common hit $3.6M or $(0.37)/share. Cash climbed to $4.9M on $42.8M investing inflows from asset dispositions, yet related-party debt of $104M looms with HCLP defaults. Nasdaq bids Nasdaq compliance hangs on reverse split vote.
8-K
Q2 costs cut 38.8%
Beneficient reported Q2 fiscal 2026 results on November 14, 2025, slashing operating expenses 38.8% to $13.4M (adjusted) versus prior year amid asset sales yielding $46.4M YTD proceeds for debt paydown. Investments fell to $244M, backing a $223M net loan portfolio, while leadership converted $52.6M preferred into common stock. Nasdaq compliance regained. Expenses dropped sharply.
IPO
Website
Employees
Sector
Industry
ALTI
AlTi Global, Inc.
5.05-0.06
BBUC
Brookfield Business Corporation
35.86+0.23
BCG
Binah Capital Group, Inc.
2.06+0.01
BEN
Franklin Resources, Inc.
23.47-0.15
BST
BlackRock Science and Technolog
39.90+0.04
BSTZ
BlackRock Science and Technolog
22.31+0.09
BTX
BlackRock Technology and Privat
6.48-0.07
DEFT
Defi Technologies, Inc.
1.05+0.04
NTRS
Northern Trust Corporation
138.27-1.35
WT
WisdomTree, Inc.
11.66-0.01